CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple myeloma
CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple myeloma
GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma
Updated results from KEYNOTE-426 for metastatic kidney cancer
METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer
ASCO 2020: Breast cancer roundup
Perioperative novel systemic immunotherapy-based approaches in urinary cancers
Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer
COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic
COVID-19: Using oncology drugs and surgery during the coronavirus pandemic
Immune checkpoint based approaches in AML and MDS
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer